We continue to expand and welcome Catharina Forzelius as our Program Director

Scandinavian Biopharma continues to expand and strengthens the organisation by recruiting Catharina Forzelius to the new position as Program Director.  As the Program Director Catharina will coordinate and lead the development and commercialisation programmes of the company’s ETEC vaccine candidate ETVAX®.

Catharina has extensive experience from positions at pharmaceutical industries as well as different governmental agencies. She has been Group Manager of the unit for Clinical Trials and Licenses at the Swedish Medical Products Agency, Project Manager and Medical Assessor at TLV (The Dental and Pharmaceutical Benefits Agency) and has had different clinical operations positions at Pfizer and GSK.

– I am very excited to join this entrepreneurial company. As the Program Director you really need to be a team player. We all share the same goal, a successful development of the world’s first ETEC vaccine, and to achieve this we need to be aligned and work in cross-functional teams. This is something I really enjoy, and I also look forward to this role since it requires both operational management and strategic oversight, says Catharina.

– I am very pleased to welcome Catharina to our newly created role as Program Director. Her experience of working in and leading both Swedish and international cross-functional teams, in combination with her experience from both the Medical Products Agency and the private sector, will come in very handy, says Björn Sjöstrand, CEO of Scandinavian Biopharma.



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.